What will introducing and delivering new maternal vaccines cost in Ghana and Mozambique? A prospective analysis.

ABSTRACT:

Introduction

The maternal vaccine landscape is expanding, including the anticipated global rollout of the now approved respiratory syncytial virus maternal vaccine. Integrating maternal immunization (MI) into health systems in low-and middle-income countries (LMICs) will require adaptation to existing immunization delivery platforms and have cost implications. In this study, we project the cost of maternal vaccine introduction and delivery in Ghana and Mozambique to help inform introduction decisions and ensure financial sustainability of future MI interventions.

Methods

We used an activity-based prospective cost projection approach to estimate MI introduction and delivery costs for a five-year period from a health system perspective. Country stakeholders informed the strate

SUBMITTER: Baral R 

PROVIDER: S-EPMC11878280 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature